Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 22
Encontrada(s) 1 página(s)

RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Cancer Epigenetic Biomarkers in Liquid Biopsy for High Incidence Malignancies

  • Palanca-Ballester, Cora
  • Rodriguez-Casanova, Aitor
  • Torres, Susana
  • Calabuig-Fariñas, Silvia
  • Exposito, Francisco
  • Serrano, Diego
  • Redin, Esther
  • Valencia, Karmele
  • Diaz-Lagares, Angel
  • Montuenga, Luis
  • Sandoval, Juan
  • Calvo, Alfonso
  • Jantus-Lewintre, Eloisa|||0000-0001-7395-4380
[EN] Early alterations in cancer include the deregulation of epigenetic events such as changes in DNA methylation and abnormal levels of non-coding (nc)RNAs. Although these changes can be identified in tumors, alternative sources of samples may offer advantages over tissue biopsies. Because tumors shed DNA, RNA, and proteins, biological fluids containing these molecules can accurately reflect alterations found in cancer cells, not only coming from the primary tumor, but also from metastasis and from the tumor microenvironment (TME). Depending on the type of cancer, biological fluids encompass blood, urine, cerebrospinal fluid, and saliva, among others. Such samples are named with the general term "liquid biopsy" (LB). With the advent of ultrasensitive technologies during the last decade, the identification of actionable genetic alterations (i.e., mutations) in LB is a common practice to decide whether or not targeted therapy should be applied. Likewise, the analysis of global or specific epigenetic alterations may also be important as biomarkers for diagnosis, prognosis, and even for cancer drug response. Several commercial kits that assess the DNA promoter methylation of single genes or gene sets are available, with some of them being tested as biomarkers for diagnosis in clinical trials. From the tumors with highest incidence, we can stress the relevance of DNA methylation changes in the following genes found in LB: SHOX2 (for lung cancer); RASSF1A, RARB2, and GSTP1 (for lung, breast, genitourinary and colon cancers); and SEPT9 (for colon cancer). Moreover, multi-cancer high-throughput methylation-based tests are now commercially available. Increased levels of the microRNA miR21 and several miRNA- and long ncRNA-signatures can also be indicative biomarkers in LB. Therefore, epigenetic biomarkers are attractive and may have a clinical value in cancer. Nonetheless, validation, standardization, and demonstration of an added value over the common clinical practice are issues needed to be addressed in the transfer of this knowledge from "bench to bedside"., A.C. and L.M. were funded by FIMA (Foundation for Applied Medical Research), ISCIIIFondo de Investigación Sanitaria-Fondo Europeo de Desarrollo Regional Una manera de hacer Europa (PI19/00230, to AC; PI19/00098 to LMM), CIBERONC CB16/12/00443, AECC, and Ramón Areces Foundations (all to L.M.). J.S. was funded by FIS grant (PI19/00572) from the FEDER, FSE, Carlos III Health Institute (ISCIII) and INNVA1/2020/71 de la Línea 1 de Valorización y Transferencia a las empresas, de la Agencia Valenciana de la Innovación. E.J-L. was supported by the Spanish Health Institute Carlos III (ISCII, Fondo de Investigación Sanitaria: CB16/12/00350 and PI18/00266). S.T. was supported by the Generalitat Valenciana and Fondo Social Europeo, fellowship ACIF/2018/275. A.D-L. was funded by a contract Juan Rodés from Spanish Health Institute Carlos III (ISCIII) (JR17/00016) and by a research grant (PI18/00307) co-funded by ISCIII and the European Regional Development Fund (FEDER). A.R-C. was supported by the Roche-CHUS Joint Unit (IN853B2018/03) funded by GAIN, Consellería de Economía, Emprego e Industria . Fellowship support: E.R. FPU, Spanish Ministry of Education ; D.S., Juan de la Cierva-Incorporacion, Spanish Ministry of Science and Innovation .
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Anxiety and depressive symptoms, and stress biomarkers in pregnant women after in vitro fertilization: a prospective cohort study

  • García Blanco, Ana
  • Diago, Vicente
  • Ghosn, Farah
  • Vento, Máximo
  • Cháfer-Pericás, Consuelo
  • Hervás-Marín, David|||0000-0003-0635-4961
[EN] STUDY QUESTION: Does in vitro fertilization (IVF) affect the course of anxiety and depressive symptoms as well as physiological stress from pregnancy to postpartum period?, MV funded by FIS PI17/0131 grant from the Instituto de Salud Carlos III (ISCIII) and RETICS funded by the PN 2018-2011, and the European Regional Development Fund, reference RD16/0022/0001; AG-B funded by a 'Juan Rodes' Grant (JR17/00003) from the ISCIII. CC-P funded by a 'Miguel Servet I' Grant (CP16/00082) from the ISCIII.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Cumulative life stressors and stress response to threatened preterm labour as birth date predictors

  • Campos-Berga, Laura
  • Moreno-Giménez, Alba
  • Vento, Máximo
  • Diago, Vicente
  • Sáenz, Pilar
  • Cháfer-Pericás, Consuelo
  • García-Blanco, Ana
  • Hervás-Marín, David|||0000-0003-0635-4961
[EN] Purpose Preterm birth represents one of the main causes of neonatal morbimortality and a risk factor for neurodevelopmental disorders. Appropriate predictive methods for preterm birth outcome, which consequently would facilitate prevention programs, are needed. We aim to predict birth date in women with a threatened preterm labour (TPL) based on stress response to TPL diagnosis, cumulative life stressors, and relevant obstetric variables. Methods A prospective cohort of 157 pregnant women with TPL diagnosis between 24 and 31 weeks gestation formed the study sample. To estimate the stress response to TPL, maternal salivary cortisol, alpha-amylase levels, along with anxiety and depression symptoms were measured. To determine cumulative life stressors, previous traumas, social support, and family functioning were registered. Then, linear regression models were used to examine the effect of potential predictors of birth date. Results Lower family adaptation, higher Body Mass Index (BMI), higher cortisol levels and TPL diagnosis week were the main predictors of birth date. Gestational week at TPL diagnosis showed a non-linear interaction with cortisol levels: TPL women with middle- and high-cortisol levels before 29 weeks of gestation went into imminent labour. Conclusion A combination of stress response to TPL diagnosis (salivary cortisol) and cumulative life stressors (family adaptation) together with obstetric factors (TPL gestational week and BMI) was the best birth date predictor. Therefore, a psychosocial therapeutic intervention program aimed to increase family adaptation and decrease cortisol levels at TPL diagnosis as well as losing weight, may prevent preterm birth in symptomatic women., Prior to study initiation, a grant was awarded by the Instituto de Salud Carlos III (PI18/01352). To achieve this grant, the project was assessed by an external peer review panel, guaranteeing scientific quality and ethical integrity. MV acknowledges PI17/0131 grant from the Instituto de Salud Carlos III (Spanish Ministry of Economy and Competitiveness) (ISCIII; Plan Estatal de I + D + I 2013-2016) and co-financed by the European Development Regional Fund "A way to achieve Europe" (ERDF); and RETICS funded by the PN 2018-2011 (Spain), ISCIII-Sub-Directorate General for Research Assessment and Promotion and the European Regional Development Fund (FEDER), RD16/0022/0001.VD acknowledges PI18/01352 grant from the ISCIII. CC-P acknowledges a "Miguel Servet I" grant (CP16/00082) from the ISCIII. AG-B acknowledges a "Juan Rodes" grant (JR17/00003) and a health research project (PI18/01352) from the ISCIII. LC-B acknowledges a "Rio Hortega" grant (CM20/00143) from the ISCIII.
RUC. Repositorio da Universidade da Coruña
Publication Artículo científico (JournalArticle)

Characterizing the Invasive Tumor Front of Aggressive Uterine Adenocarcinoma and Leiomyosarcoma

  • Sanegre, Sabina
  • Eritja, Núria
  • Andrea, Carlos de
  • Díaz-Martín, Juan
  • Díaz-Lagares, Ángel
  • Jácome, M. A.
  • Salguero Aranda, Carmen
  • García-Ros, David
  • Davidson, Ben
  • López-López, Rafael
  • Melero, Ignacio
  • Navarro, Samuel
  • Ramón y Cajal, Santiago
  • Alava, Enrique de
  • Matias-Guiu, Xavier
  • Noguera, Rosa
[Abstract] The invasive tumor front (the tumor–host interface) is vitally important in malignant cell progression and metastasis. Tumor cell interactions with resident and infiltrating host cells and with the surrounding extracellular matrix and secreted factors ultimately determine the fate of the tumor. Herein we focus on the invasive tumor front, making an in-depth characterization of reticular fiber scaffolding, infiltrating immune cells, gene expression, and epigenetic profiles of classified aggressive primary uterine adenocarcinomas (24 patients) and leiomyosarcomas (11 patients). Sections of formalin-fixed samples before and after microdissection were scanned and studied. Reticular fiber architecture and immune cell infiltration were analyzed by automatized algorithms in colocalized regions of interest. Despite morphometric resemblance between reticular fibers and high presence of macrophages, we found some variance in other immune cell populations and distinctive gene expression and cell adhesion-related methylation signatures. Although no evident overall differences in immune response were detected at the gene expression and methylation level, impaired antimicrobial humoral response might be involved in uterine leiomyosarcoma spread. Similarities found at the invasive tumor front of uterine adenocarcinomas and leiomyosarcomas could facilitate the use of common biomarkers and therapies. Furthermore, molecular and architectural characterization of the invasive front of uterine malignancies may provide additional prognostic information beyond established prognostic factors., This research was supported by grants from the ISCIII and ERDF (PI17/01558 and PI20/01107), by the CIBERONC (contracts CB16/12/00484, CB16/12/0328, CB16/12/00363, CB16/12/00364, CB16/12/00481, and CB16/12/00231) and Grupos Coordinados Estables from the Asociación Española Contra el Cáncer (AECC). ÁD-L was funded by a contract “Juan Rodés” from the ISCIII (JR17/00016).
RUC. Repositorio da Universidade da Coruña
Publication Artículo científico (JournalArticle)

Epigenomic Analysis Reveals a Unique DNA Methylation Program of Metastasis-Competent Circulating Tumor Cells in Colorectal Cancer

  • Bao-Caamano, Aida
  • Costa-Fraga, Nicolás
  • Cayrefourcq, Laure
  • Jácome, M. A.
  • Rodríguez-Casanova, Aitor
  • Muinelo Romay, Laura
  • López-López, Rafael
  • Alix-Panabières, Catherine
  • Díaz-Lagares, Ángel
[Abstract] Circulating tumor cells (CTCs) and epigenetic alterations are involved in the development of metastasis from solid tumors, such as colorectal cancer (CRC). The aim of this study was to characterize the DNA methylation profile of metastasis-competent CTCs in CRC. The DNA methylome of the human CRC-derived cell line CTC-MCC-41 was analyzed and compared with primary (HT29, Caco2, HCT116, RKO) and metastatic (SW620 and COLO205) CRC cells. The association between methylation and the transcriptional profile of CTC-MCC-41 was also evaluated. Differentially methylated CpGs were validated with pyrosequencing and qMSP. Compared to primary and metastatic CRC cells, the methylation profile of CTC-MCC-41 was globally different and characterized by a slight predominance of hypomethylated CpGs mainly distributed in CpG-poor regions. Promoter CpG islands and shore regions of CTC-MCC-41 displayed a unique methylation profile that was associated with the transcriptional program and relevant cancer pathways, mainly Wnt signaling. The epigenetic regulation of relevant genes in CTC-MCC-41 was validated. This study provides new insights into the epigenomic landscape of metastasis-competent CTCs, revealing biological information for metastasis development, as well as new potential biomarkers and therapeutic targets for CRC patients., This research was funded by the ISCIII (PI18/00307) and the European Regional Development Fund (FEDER), and by the Liquid Biopsy Crowdfunding campaign organized by ONCOMET in 2017. We would like to thank all donors who participated in the Liquid Biopsy Crowdfunding campaign organized by ONCOMET in 2017. AB-C is funded by a predoctoral contract PFIS (FI19/00240) from “Instituto de Salud Carlos III” (ISCIII) co-funded by “Fondo Social Europeo” (FSE). NC-F is funded by a predoctoral contract from “Xunta de Galicia” (IN606A-2020/004). AR-C is supported by the Roche-Chus Joint Unit (IN853B 2018/03) funded by “Axencia Galega de Innovación (GAIN), Vicepresidencia Segunda e Consellería de Economía, Empresa e Innovación”. LM-R is funded by a contract “Miguel Servet” from ISCIII (CP20/00129). CA-P is supported by funding from the European Union Horizon 2020 Research and Innovation program under the Marie Skłodowska-Curie grant agreement No. 765492, by The National Institute of Cancer (INCa, http://www.e-cancer.fr), SIRIC Montpellier Cancer Grant INCa_Inserm_DGOS_12553, and the ERA-NET TRANSCAN 2 JTC 2016 PROLIPSY, la Fondation ARC pour la Recherche sur le cancer and les Fonds de dotation AFER pour la recherche médicale. AD-L was funded by a contract “Juan Rodés” (JR17/00016) from “Instituto de Salud Carlos III” (ISCIII) and by Servizo Galego de Saúde (SERGAS). All authors have read the journal's policy on disclosure of potential conflicts of interest, and have disclosed any financial or personal relationship with organizations that could potentially be perceived as influencing the described research, Xunta de Galicia; IN606A-2020/004, Xunta de Galicia; IN853B 2018/03, Francia. Institut National du Cancer; INCa_Inserm_DGOS_12553
DAU Arxiu Digital de la Universitat Ramon Llull
Publication Artículo científico (JournalArticle)

Yearly attained adherence to Mediterranean diet and incidence of diabetes in a large randomized trial

  • Martínez-González, Miguel Ángel, 1957-
  • Montero, Pedro
  • Ruiz-Canela, Miguel
  • Toledo, Estefanía
  • Estruch Riba, Ramon
  • Gómez-Gracia, Enrique
  • Li, Jun
  • Ros Rahola, Emilio
  • Arós, Fernando
  • Hernáez, Álvaro
  • Corella Piquer, Dolores
  • Fiol, Miquel
  • Lapetra, José
  • Serra Majem, Lluís
  • Pintó Sala, Xavier
  • Cofán Pujol, Montserrat
  • Sorlí, José V.
  • Babio, Nancy
  • Márquez-Sandoval, Yolanda F.
  • Castañer, Olga
  • Salas Salvadó, Jordi
Background Several large observational prospective studies have reported a protection by the traditional Mediterranean diet against type 2 diabetes, but none of them used yearly repeated measures of dietary intake. Repeated measurements of dietary intake are able to improve subject classification and to increase the quality of the assessed relationships in nutritional epidemiology. Beyond observational studies, randomized trials provide stronger causal evidence. In the context of a randomized trial of primary cardiovascular prevention, we assessed type 2 diabetes incidence according to yearly repeated measures of compliance with a nutritional intervention based on the traditional Mediterranean diet. Methods PREDIMED (‘‘PREvención con DIeta MEDiterránea’’) was a Spanish trial including 7447 men and women at high cardiovascular risk. We assessed 3541 participants initially free of diabetes and originally randomized to 1 of 3 diets: low-fat diet (n = 1147, control group), Mediterranean diet supplemented with extra virgin olive (n = 1154) or Mediterranean diet supplemented with mixed nuts (n = 1240). As exposure we used actual adherence to Mediterranean diet (cumulative average), yearly assessed with the Mediterranean Diet Adherence Screener (scoring 0 to 14 points), and repeated up to 8 times (baseline and 7 consecutive follow-up years). This score was categorized into four groups: < 8, 8–< 10, 10– < 12, and 12–14 points. The outcome was new-onset type 2 diabetes. Results Multivariable-adjusted hazard ratios from time-varying Cox models were 0.80 (95% confidence interval, 0.70–0.92) per + 2 points in Mediterranean Diet Adherence Screener (linear trend p = .001), and 0.46 (0.25–0.83) for the highest (12–14 points) versus the lowest (< 8) adherence. This inverse association was maintained after additionally adjusting for the randomized arm. Age- and sex-adjusted analysis of a validated plasma metabolomic signature of the Mediterranean Diet Adherence Screener (constituted of 67 metabolites) in a subset of 889 participants also supported these results. Conclusions Dietary intervention trials should quantify actual dietary adherence throughout the trial period to enhance the benefits and to assist results interpretation. A rapid dietary assessment tool, yearly repeated as a screener, was able to capture a strong inverse linear relationship between Mediterranean diet and type 2 diabetes., info:eu-repo/semantics/publishedVersion
DAU Arxiu Digital de la Universitat Ramon Llull
Publication Artículo científico (JournalArticle)

Cancer signaling transcriptome is upregulated in type 2 diabetes mellitus

  • Almanza Aguilera, Enrique
  • Hernáez, Álvaro
  • Corella Piquer, Dolores
  • Sanllorente Melenchon, Albert
  • Ros Rahola, Emilio
  • Portolés, Olga
  • Valussi, Julieta
  • Estruch Riba, Ramon
  • Coltell, Oscar
  • Subirana, Isaac
  • Canudas i Puig, Sílvia
  • Razquin, Cristina
  • Blanchart, Gemma
  • Nonell, Lara
  • Fitó Colomer, Montserrat
  • Castañer, Olga
We aimed to explore the differences in the whole transcriptome of peripheral blood mononuclear cells between elderly individuals with and without type 2 diabetes (T2D). We conducted a microarray-based transcriptome analysis of 19 individuals with T2D and 15 without. Differentially expressed genes according to linear models were submitted to the Ingenuity Pathway Analysis system to conduct a functional enrichment analysis. We established that diseases, biological functions, and canonical signaling pathways were significantly associated with T2D patients when their logarithms of Benjamini–Hochberg-adjusted p-value were >1.30 and their absolute z-scores were >2.0 (≥2.0 meant “upregulation” and ≤−2.0 “downregulation”). Cancer signaling pathways were the most upregulated ones in T2D (z-score = 2.63, −log(p-value) = 32.3; 88.5% (n = 906) of the total differentially expressed genes located in these pathways). In particular, integrin (z-score = 2.52, −log(p-value) = 2.03) and paxillin (z-score = 2.33, −log(p-value) = 1.46) signaling pathways were predicted to be upregulated, whereas the Rho guanosine diphosphate (Rho-GDP) dissociation inhibitor signaling pathway was predicted to be downregulated in T2D individuals (z-score = −2.14, −log(p-value) = 2.41). Our results suggest that, at transcriptional expression level, elderly individuals with T2D present an increased activation of signaling pathways related to neoplastic processes, T-cell activation and migration, and inflammation.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Reseña (Review)

Utilidad de la tomografía de coherencia óptica en la evaluación de los pacientes con trastorno bipolar

  • Gavín, A.
  • Garcia-Martin, E.
  • Garcia-Campayo, J.
  • Viladés, E.
  • Orduna, E.
  • Satué, M.
El trastorno bipolar (TB) es una enfermedad mental caracterizada por episodios de alteraciones extremas del humor en la que existe evidencia de presencia de neurodegeneración, determinada mediante resonancia magnética nuclear. En los últimos años, la evaluación del nervio óptico y de las capas de la retina mediante tomografía de coherencia óptica (OCT) en enfermedades neurodegenerativas ha demostrado su utilidad como biomarcador no invasivo de diagnóstico y progresión. En pacientes con TB diversos estudios han encontrado disminución de la capa de fibras nerviosas de la retina y del complejo de células ganglionares objetivables mediante OCT, lo que apoyaría la hipótesis de que el TB se trata de una enfermedad neurodegenerativa además de un proceso psiquiátrico. Por ello, el estudio neuro-oftalmológico de estos pacientes podría servir como marcador diagnóstico de esta patología. Este trabajo revisa la bibliografía reciente sobre degeneración retiniana en pacientes con TB y evalúa la capacidad de los dispositivos de OCT en la detección de degeneración neuronal que afecta a las diferentes capas de la retina en estos pacientes y su posible papel en el diagnóstico y seguimiento de la enfermedad. Bipolar disorder (BD) is a mental disorder characterised by episodes of extremal mood changes. In recent years, some researchers found neurodegeneration in patients with BD using Magnetic Resonance Imaging. Evaluation of the optic nerve and the retinal layers using optical coherence tomography (OCT) has proved to be a useful, non-invasive tool for diagnosis and monitoring of neurodegenerative diseases. Accordingly, a decrease in the retinal nerve fibre layer and the ganglion cell complex measured by OCT was found in patients with BD in different studies, suggesting that BD is a neurodegenerative process in addition to a psychiatric disorder. Therefore, the neuro-ophthalmological evaluation of these patients could be used as a marker for diagnosis of this disease. This work analyses literature on retinal degeneration in bipolar disorder patients, and evaluates the ability of OCT devices in the detection of neuronal degeneration affecting the different retinal layers in these patients, and its possible role in the diagnosis and monitoring of the disease.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Yearly attained adherence to Mediterranean diet and incidence of diabetes in a large randomized trial

  • Martínez-González, Miguel Ángel, 1957-
  • Montero, Pedro
  • Ruiz-Canela, Miguel
  • Toledo, Estefanía
  • Estruch Riba, Ramon
  • Gómez-Gracia, Enrique
  • Li, Jun
  • Ros Rahola, Emilio
  • Arós, Fernando
  • Hernáez, Álvaro
  • Corella Piquer, Dolores
  • Fiol, Miquel
  • Lapetra, José
  • Serra Majem, Lluís
  • Pintó Sala, Xavier
  • Cofán Pujol, Montserrat
  • Sorlí, José V.
  • Babio, Nancy
  • Márquez-Sandoval, Yolanda F.
  • Castañer, Olga
  • Salas Salvadó, Jordi
Background Several large observational prospective studies have reported a protection by the traditional Mediterranean diet against type 2 diabetes, but none of them used yearly repeated measures of dietary intake. Repeated measurements of dietary intake are able to improve subject classification and to increase the quality of the assessed relationships in nutritional epidemiology. Beyond observational studies, randomized trials provide stronger causal evidence. In the context of a randomized trial of primary cardiovascular prevention, we assessed type 2 diabetes incidence according to yearly repeated measures of compliance with a nutritional intervention based on the traditional Mediterranean diet. Methods PREDIMED (‘‘PREvención con DIeta MEDiterránea’’) was a Spanish trial including 7447 men and women at high cardiovascular risk. We assessed 3541 participants initially free of diabetes and originally randomized to 1 of 3 diets: low-fat diet (n = 1147, control group), Mediterranean diet supplemented with extra virgin olive (n = 1154) or Mediterranean diet supplemented with mixed nuts (n = 1240). As exposure we used actual adherence to Mediterranean diet (cumulative average), yearly assessed with the Mediterranean Diet Adherence Screener (scoring 0 to 14 points), and repeated up to 8 times (baseline and 7 consecutive follow-up years). This score was categorized into four groups: < 8, 8–< 10, 10– < 12, and 12–14 points. The outcome was new-onset type 2 diabetes. Results Multivariable-adjusted hazard ratios from time-varying Cox models were 0.80 (95% confidence interval, 0.70–0.92) per + 2 points in Mediterranean Diet Adherence Screener (linear trend p = .001), and 0.46 (0.25–0.83) for the highest (12–14 points) versus the lowest (< 8) adherence. This inverse association was maintained after additionally adjusting for the randomized arm. Age- and sex-adjusted analysis of a validated plasma metabolomic signature of the Mediterranean Diet Adherence Screener (constituted of 67 metabolites) in a subset of 889 participants also supported these results. Conclusions Dietary intervention trials should quantify actual dietary adherence throughout the trial period to enhance the benefits and to assist results interpretation. A rapid dietary assessment tool, yearly repeated as a screener, was able to capture a strong inverse linear relationship between Mediterranean diet and type 2 diabetes., info:eu-repo/semantics/publishedVersion
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Cancer signaling transcriptome is upregulated in type 2 diabetes mellitus

  • Almanza Aguilera, Enrique
  • Hernáez, Álvaro
  • Corella Piquer, Dolores
  • Sanllorente Melenchon, Albert
  • Ros Rahola, Emilio
  • Portolés, Olga
  • Valussi, Julieta
  • Estruch Riba, Ramon
  • Coltell, Oscar
  • Subirana, Isaac
  • Canudas i Puig, Sílvia
  • Razquin, Cristina
  • Blanchart, Gemma
  • Nonell, Lara
  • Fitó Colomer, Montserrat
  • Castañer, Olga
We aimed to explore the differences in the whole transcriptome of peripheral blood mononuclear cells between elderly individuals with and without type 2 diabetes (T2D). We conducted a microarray-based transcriptome analysis of 19 individuals with T2D and 15 without. Differentially expressed genes according to linear models were submitted to the Ingenuity Pathway Analysis system to conduct a functional enrichment analysis. We established that diseases, biological functions, and canonical signaling pathways were significantly associated with T2D patients when their logarithms of Benjamini–Hochberg-adjusted p-value were >1.30 and their absolute z-scores were >2.0 (≥2.0 meant “upregulation” and ≤−2.0 “downregulation”). Cancer signaling pathways were the most upregulated ones in T2D (z-score = 2.63, −log(p-value) = 32.3; 88.5% (n = 906) of the total differentially expressed genes located in these pathways). In particular, integrin (z-score = 2.52, −log(p-value) = 2.03) and paxillin (z-score = 2.33, −log(p-value) = 1.46) signaling pathways were predicted to be upregulated, whereas the Rho guanosine diphosphate (Rho-GDP) dissociation inhibitor signaling pathway was predicted to be downregulated in T2D individuals (z-score = −2.14, −log(p-value) = 2.41). Our results suggest that, at transcriptional expression level, elderly individuals with T2D present an increased activation of signaling pathways related to neoplastic processes, T-cell activation and migration, and inflammation.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Spontaneous portosystemic shunt embolization in liver transplant recipients with recurrent hepatic encephalopathy

  • Álvarez López, Patricia
  • Quiroga Gómez, Sergi
  • Díez Miranda, Iratxe
  • Charco Torra, Ramon
  • Simon-Talero Horga, Macarena
  • Castells Fusté, Lluis
  • Campos Varela, Isabel
Angiogenesis; Portal hypertension; Collateral vessels, Angiogénesis; Hipertensión portal; Vasos colaterales, Angiogènesi; Hipertensió portal; Vasos col·laterals, Introduction and objectives Spontaneous portosystemic shunts (SPSS) are a common cause of recurrent hepatic encephalopathy (HE). Shunt occlusion is an effective and safe procedure when performed in patients with cirrhosis and preserved liver function. We aimed to describe our experience with SPSS embolization after liver transplantation (LT). Patients We identified five patients who underwent SPSS embolization after LT. Clinical, biochemical and technical procedure data were collected. Results At presentation, all patients had developed graft cirrhosis and HE after LT. Median Model for End-stage Liver Disease (MELD) at embolization was 9 (range 7-12), median Child-Pugh was 8 (range 7-9). Splenorenal and mesocaval shunt were the most frequent types of SPSS found. Three patients have been completely free of HE. Of the two patients who had HE recurrence after embolization, one patient had two episodes of HE which was controlled well with medications. The other patient required three embolizations because of recurrent HE. Median follow-up was 4.4 years (range 1.0-5.0) and MELD score at last follow up was 13 (range 10-18) and median Child-Pugh score B, 7 points (range 5-12). Conclusions SPSS can be considered as a cause of HE after LT. SPSS embolization is feasible and safe in LT recipients., Isabel Campos-Varela's research activity is funded by grant PI19/00330, funded by Instituto de Salud Carlos III and co-funded by European Union (ERDF/ESF) - A way to build Europe. Macarena Simón-Talero is a recipient of the Juan Rodés grant JR17/00029 from Instituto de Salud Carlos III, Spain. CIBERehd is supported by Instituto de Salud Carlos III. The work was independent of all funding.
Dipòsit Digital de Documents de la UAB
Publication Artículo de revisión (ReviewArticle)

The Gut Microbiome Profile in Obesity, A Systematic Review

  • Castañer, Olga|||0000-0003-3169-997X
  • Goday Arnó, Albert|||0000-0001-7356-1595
  • Park, Yong-Moon
  • Lee, Seung-Hwan|||0000-0002-3964-3877
  • Magkos, Faidon
  • Shiow, Sue-Anne Toh Ee
  • Schröder, Helmut|||0000-0003-2231-5081
Gut microbiome has been identified in the past decade as an important factor involved in obesity, but the magnitude of its contribution to obesity and its related comorbidities is still uncertain. Among the vast quantity of factors attributed to obesity, environmental, dietary, lifestyle, genetic, and others, the microbiome has aroused curiosity, and the scientific community has published many original articles. Most of the studies related to microbiome and obesity have been reported based on the associations between microbiota and obesity, and the in-depth study of the mechanisms related has been studied mainly in rodents and exceptionally in humans. Due to the quantity and diverse information published, the need of reviews is mandatory to recapitulate the relevant achievements. In this systematic review, we provide an overview of the current evidence on the association between intestinal microbiota and obesity. Additionally, we analyze the effects of an extreme weight loss intervention such as bariatric surgery on gut microbiota. The review is divided into 2 sections: first, the association of obesity and related metabolic disorders with different gut microbiome profiles, including metagenomics studies, and second, changes on gut microbiome after an extreme weight loss intervention such as bariatric surgery.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Caveats and pitfalls of SOX1 autoantibody testing with a commercial line blot assay in paraneoplastic neurological investigations

  • Ruiz-García, Raquel
  • Martínez Hernández, Eugenia
  • García-Ormaechea, Milagros
  • Español-Rego, Marta|||0000-0001-5497-2276
  • Sabater, Lidia
  • Querol, Luis|||0000-0002-4289-8264
  • Illa, Isabel|||0000-0002-2186-2684
  • Dalmau, Josep|||0000-0001-5856-2813
  • Graus Ribas, Francesc|||0000-0002-8924-8322
SOX1 autoantibodies are considered markers of small cell lung cancer (SCLC) and paraneoplastic neurological syndromes (PNS) and are usually determined by commercial line blot in many clinical services. Recent studies suggested that SOX1 autoantibodies also occur in patients with neuropathies unrelated to SCLC, questioning the value of SOX1 autoantibodies as paraneoplastic biomarkers. Here, we compared the specificity and sensitivity of a commercial line blot (Euroimmun, Lübeck, Germany) with those of an in house cell-based assay (CBA) with HEK293 cells transfected with SOX1. Overall, 210 patients were included in the study, 139 patients with polyneuropathies without SCLC, and 71 with disorders associated with SOX1 autoantibodies detected with the in-house CBA. Forty one of these 71 cases had been referred to our laboratory for onconeuronal antibody assessment and 30/71 were patients with known PNS and SCLC. None of the patients with polyneuropathies had SOX1 autoantibodies by either line blot or CBA (specificity of the immunoblot: 100%; 95%C.I.: 97.8-100). Among the 71 patients with CBA SOX1 autoantibodies, only 53 were positive by line blot (sensitivity: 74.6%; 95%C.I.: 62.9-84.2). Lung cancer was detected in 37/41 (90%; 34 with SCLC) patients referred for onconeuronal antibody assessment and 34 of them also had a PNS. Our study confirms the association of SOX1 autoantibodies with SCLC and PNS. The line blot test misses 25% of the cases; therefore, to minimize the frequency of false negative results we recommend the use of a confirmatory test, such as CBA, in patients suspected to have a SCLC-related PNS.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Short- and medium-term impact of bariatric surgery on the activities of CYP2D6, CYP3A4, CYP2C9, and CYP1A2 in morbid obesity

  • Rodríguez-Morató, Jose|||0000-0002-8133-9983
  • Goday Arnó, Albert|||0000-0001-7356-1595
  • Langohr, Klaus|||0000-0001-7075-9192
  • Pujadas, Mitona|||0000-0002-0506-3030
  • Civit, Ester
  • Pérez-Mañá, Clara|||0000-0001-6343-6918
  • Papaseit, Esther|||0000-0003-2620-4274
  • Ramon, Jose Manuel
  • Benaiges, David|||0000-0001-5411-364X
  • Castañer, Olga|||0000-0003-3169-997X
  • Farré Albaladejo, Magí|||0000-0001-8338-7543
  • Torre, Rafael de la|||0000-0002-6765-1866
Morbid obesity and bariatric surgery induce anatomical, physiological and metabolic alterations that may alter the body's disposition of drugs. Current literature on this topic is limited and sometimes inconsistent. Cytochrome P450 (CYP) is a superfamily of enzymes that metabolize around 75% of all marketed drugs. The purpose of this study was to evaluate the impact of body mass index and bariatric surgery on CYP activities. Firstly, we evaluated the in vivo activity of 4 major CYP isoenzymes (CYP2D6, CYP3A4, CYP2C9, and CYP1A2) in normal weight, overweight, and morbidly obese individuals. Secondly, we assessed the short- (1 month) and medium-term (6 month) effects of the most commonly employed bariatric surgery techniques (laparoscopic sleeve gastrectomy and Roux-en-Y gastric bypass) on the activity of these enzymes. CYP3A4 activity was lower in morbidly obese individuals, compared to normal-weight controls. Interestingly, bariatric surgery normalized CYP3A4 activity. In comparison with normal-weight controls, morbidly obese individuals had higher CYP2D6 activity, which was only observed in individuals with two functional alleles for this isoenzyme. Neither body mass index nor surgery had significant effects on CYP2C9 and CYP1A2 activities. Overall, no relevant differences in CYP activities were found between surgical techniques. In conclusion, further studies should evaluate whether the observed alterations in CYP3A4 activity will require dose adjustments for CYP3A4 substrates especially in morbidly obese individuals before and after bariatric surgery.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Isotemporal substitution of inactive time with physical activity and time in bed, cross-sectional associations with cardiometabolic health in the PREDIMED-Plus study

  • Galmes-Panades, Aina M.|||0000-0001-6977-9874
  • Varela-Mato, Veronica
  • Konieczna, Jadwiga|||0000-0002-2947-1338
  • Wärnberg, Julia|||0000-0002-8408-316X
  • Martínez González, Miguel Ángel|||0000-0002-3917-9808
  • Salas-Salvadó, Jordi|||0000-0003-2700-7459
  • Corella, Dolores|||0000-0002-2366-4104
  • Schröder, Helmut|||0000-0003-2231-5081
  • Vioque, Jesús|||0000-0002-2284-148X
  • Alonso-Gómez, Ángel María|||0000-0003-2945-7509
  • Martínez, J. Alfredo|||0000-0001-5218-6941
  • Serra-Majem, Luís|||0000-0002-9658-9061
  • Estruch, Ramón|||0000-0003-1260-4445
  • Tinahones, Francisco J.|||0000-0001-6871-4403
  • Lapetra, José|||0000-0002-3873-5737
  • Pintó, Xavier|||0000-0002-2216-2444
  • Tur, Josep Antonio|||0000-0002-6940-0761
  • García-Rios, Antonio|||0000-0001-7320-9006
  • Riquelme-Gallego, Blanca|||0000-0003-3422-7310
  • Gaforio, José J.|||0000-0003-2996-9301
  • Matía-Martín, Pilar|||0000-0001-9844-3755
  • Daimiel, Lidia|||0000-0001-9898-6629
  • Micó Pérez, Rafael Manuel|||0000-0002-2575-1236
  • Vidal, Josep|||0000-0002-4564-4518
  • Vázquez, Clotilde
  • Ros, Emilio|||0000-0002-2573-1294
  • Garcia-Arellano, Ana
  • Díaz-López, Andrés|||0000-0002-7500-5629
  • Asensio, Eva Maria|||0000-0003-4558-0988
  • Castañer, Olga|||0000-0003-3169-997X
  • Fiol, Francisca
  • Mira-Castejón, Luis Alfredo
  • Moreno Rodríguez, Anai
  • Benavente-Marín, Juan Carlos
  • Abete, Itziar|||0000-0002-6475-5387
  • Tomaino, Laura
  • Casas, Rosa|||0000-0002-0211-9166
  • Barón López, Francisco Javier|||0000-0001-8707-304X
  • Fernández-García, José C.|||0000-0003-2229-8488
  • Santos-Lozano, José Manuel
  • Galera, Ana
  • Mascaró, Catalina M.
  • Razquín, Cristina|||0000-0003-3480-2645
  • Papandreou, Christopher|||0000-0002-6803-507X
  • Portoles, Olga
  • Pérez-Vega, Karla Alejandra|||0000-0002-7524-2034
  • Fiol-Sala, Miquel
  • Compañ Gabucio, Laura M.|||0000-0001-5324-1535
  • Vaquero-Luna, Jessica
  • Ruiz-Canela, Miguel|||0000-0002-7684-2787
  • Becerra-Tomás, Nerea|||0000-0002-4429-6507
  • Fitó, Montserrat|||0000-0002-1817-483X
  • Romaguera, Dora|||0000-0002-5762-8558
This study explored the association between inactive time and measures of adiposity, clinical parameters, obesity, type 2 diabetes and metabolic syndrome components. It further examined the impact of reallocating inactive time to time in bed, light physical activity (LPA) or moderate-to-vigorous physical activity (MVPA) on cardio-metabolic risk factors, including measures of adiposity and body composition, biochemical parameters and blood pressure in older adults. This is a cross-sectional analysis of baseline data from 2189 Caucasian men and women (age 55-75 years, BMI 27-40 Kg/m 2) from the PREDIMED-Plus study (). All participants had ≥3 components of the metabolic syndrome. Inactive time, physical activity and time in bed were objectively determined using triaxial accelerometers GENEActiv during 7 days (ActivInsights Ltd., Kimbolton, United Kingdom). Multiple adjusted linear and logistic regression models were used. Isotemporal substitution regression modelling was performed to assess the relationship of replacing the amount of time spent in one activity for another, on each outcome, including measures of adiposity and body composition, biochemical parameters and blood pressure in older adults. Inactive time was associated with indicators of obesity and the metabolic syndrome. Reallocating 30 min per day of inactive time to 30 min per day of time in bed was associated with lower BMI, waist circumference and glycated hemoglobin (HbA1c) (all p -values < 0.05). Reallocating 30 min per day of inactive time with 30 min per day of LPA or MVPA was associated with lower BMI, waist circumference, total fat, visceral adipose tissue, HbA1c, glucose, triglycerides, and higher body muscle mass and HDL cholesterol (all p-values < 0.05). Inactive time was associated with a poor cardio-metabolic profile. Isotemporal substitution of inactive time with MVPA and LPA or time in bed could have beneficial impact on cardio-metabolic health.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Epigenetic silencing of TGFBI confers resistance to trastuzumab in human breast cancer

  • Palomeras, Sònia
  • Diaz-Lagares, Angel|||0000-0002-9114-9227
  • Viñas, Gemma
  • Setien, Fernando|||0000-0002-4061-4635
  • Ferreira, Humberto J.
  • Oliveras, Glòria
  • Crujeiras, Ana B.|||0000-0003-4392-0301
  • Hernández, Alejandro
  • Lum, David H.
  • Welm, Alana L.
  • Esteller, M.|||0000-0003-4490-6093
  • Puig Miquel, Teresa
Background: Acquired resistance to trastuzumab is a major clinical problem in the treatment of HER2-positive (HER2+) breast cancer patients. The selection of trastuzumab-resistant patients is a great challenge of precision oncology. The aim of this study was to identify novel epigenetic biomarkers associated to trastuzumab resistance in HER2+ BC patients. Methods: We performed a genome-wide DNA methylation (450K array) and a transcriptomic analysis (RNA-Seq) comparing trastuzumab-sensitive (SK) and trastuzumab-resistant (SKTR) HER2+ human breast cancer cell models. The methylation and expression levels of candidate genes were validated by bisulfite pyrosequencing and qRT-PCR, respectively. Functional assays were conducted in the SK and SKTR models by gene silencing and overexpression. Methylation analysis in 24 HER2+ human BC samples with complete response or non-response to trastuzumab-based treatment was conducted by bisulfite pyrosequencing. Results: Epigenomic and transcriptomic analysis revealed the consistent hypermethylation and downregulation of TGFBI, CXCL2, and SLC38A1 genes in association with trastuzumab resistance. The DNA methylation and expression levels of these genes were validated in both sensitive and resistant models analyzed. Of the genes, TGFBI presented the highest hypermethylation-associated silencing both at the transcriptional and protein level. Ectopic expression of TGFBI in the SKTR model suggest an increased sensitivity to trastuzumab treatment. In primary tumors, TGFBI hypermethylation was significantly associated with trastuzumab resistance in HER2+ breast cancer patients. Conclusions: Our results suggest for the first time an association between the epigenetic silencing of TGFBI by DNA methylation and trastuzumab resistance in HER2+ cell models. These results provide the basis for further clinical studies to validate the hypermethylation of TGFBI promoter as a biomarker of trastuzumab resistance in HER2+ breast cancer patients.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Spontaneous portosystemic shunts in liver cirrhosis, new approaches to an old problem

  • Vidal-González, Judit
  • Quiroga, Sergio|||0000-0001-8671-7616
  • Simón Talero, Macarena|||0000-0002-1409-3936
  • Genescà Ferrer, Joan|||0000-0002-0831-8422
Portal hypertension is the main consequence of liver cirrhosis, leading to severe complications such as variceal hemorrhage, ascites or hepatic encephalopathy. As an attempt to decompress the portal venous system, portal flow is derived into the systemic venous system through spontaneous portosystemic shunts (SPSSs), bypassing the liver. In this review, we aim to provide an overview of the published reports in relation to the prevalence and physiopathology behind the appearance of SPSS in liver cirrhosis, as well as the complications derived from its formation and its management. The role of SPSS embolization is specifically discussed, as SPSSs have been assessed as a therapeutic target, mainly for patients with recurrent/persistent hepatic encephalopathy and preserved liver function. Furthermore, different aspects of the role of SPSS in liver transplantation, as well as in candidates for transjugular intrahepatic portosystemic shunt are reviewed. In these settings, SPSS occlusion has been proposed to minimize possible deleterious effects, but results are so far inconclusive.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Noninvasive early detection of colorectal cancer by hypermethylation of the LINC00473 promoter in plasma cell-free DNA

  • Ruiz Bañobre, Juan|||0000-0003-0755-4295
  • Rodríguez Casanova, Aitor|||0000-0002-9828-3613
  • Costa-Fraga, Nicolás|||0000-0002-0869-8509
  • Bao Caamano, Aida
  • Álvarez Castro, Ana
  • Carreras Presas, Martín
  • Brozos Vázquez, Elena
  • Vidal Insua, Yolanda
  • Vázquez Rivera, Francisca
  • Candamio Folgar, Sonia|||0000-0003-4007-5990
  • Mosquera Presedo, Manuel|||0000-0002-9802-1082
  • Lago Lestón, Ramón M.|||0000-0002-1166-7754
  • Muinelo-Romay, Laura|||0000-0002-7456-7531
  • Vázquez Bueno, José Ángel
  • Sanz Pamplona, Rebeca|||0000-0002-2187-3527
  • Moreno Aguado, Victor Raul|||0000-0002-2818-5487
  • Goel, Ajay|||0000-0003-1396-6341
  • Castillo, Lourdes
  • Martín, Ana C.
  • Arroyo, Rocío
  • Esteller, M.|||0000-0003-4490-6093
  • Crujeiras, Ana B.|||0000-0003-4392-0301
  • López López, Rafael|||0000-0003-1315-655X
  • Diaz-Lagares, Angel|||0000-0002-9114-9227
Background: Current noninvasive assays have limitations in the early detection of colorectal cancer. We evaluated the clinical utility of promoter methylation of the long noncoding RNA LINC00473 as a noninvasive biomarker to detect colorectal cancer and associated precancerous lesions. Methods: We evaluated the epigenetic regulation of LINC00473 through promoter hypermethylation in colorectal cancer cell lines using bisulfite genomic sequencing and expression analyses. DNA methylation of LINC00473 was analyzed in primary colorectal tumors using 450K arrays and RNA-seq from The Cancer Genome Atlas (TCGA). Tissue-based findings were validated in several independent cohorts of colorectal cancer and advanced colorectal polyp patients by pyrosequencing. We explored the clinical utility of LINC00473 methylation for the early detection of colorectal cancer in plasma cell-free DNA by quantitative methylation-specific PCR and droplet digital PCR. Results: LINC00473 showed transcriptionally silencing due to promoter hypermethylation in colorectal cancer cell lines and primary tumors. Methylation of the LINC00473 promoter accurately detected primary colorectal tumors in two independent clinical cohorts, with areas under the receiver operating characteristic curves (AUCs) of 0.94 and 0.89. This biomarker also identified advanced colorectal polyps from two other tissue-based clinical cohorts with high diagnostic accuracy (AUCs of 0.99 and 0.78). Finally, methylation analysis of the LINC00473 promoter in plasma cell-free DNA accurately identified patients with colorectal cancer and advanced colorectal polyps (AUCs of 0.88 and 0.84, respectively), which was confirmed in an independent cohort of patients. Conclusions: Hypermethylation of the LINC00473 promoter is a new promising biomarker for noninvasive early detection of colorectal cancer and related precancerous lesions.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Long-term antibiotic therapy in patients with surgery-indicated not undergoing surgery infective endocarditis

  • Vallejo Camazon, Nuria
  • Mateu, Lourdes|||0000-0001-7223-7611
  • Cediel, Germán|||0000-0001-9667-7507
  • Escolà-Vergé, Laura|||0000-0002-5608-3090
  • Fernández Hidalgo, Nuria|||0000-0002-2115-344X
  • Gurguí, Mercè|||0000-0002-0474-3528
  • Pérez Rodriguez, María Teresa|||0000-0003-2944-8610
  • Cuervo, Guillermo|||0000-0002-7075-943X
  • Núñez Aragón, Raquel
  • Llibre, Cinta|||0000-0003-3618-9741
  • Sopena, Nieves|||0000-0001-6382-9500
  • Quesada, Maria Dolores|||0000-0001-8360-3787
  • Berastegui García, Elisabet|||0000-0002-1766-2970
  • Teis, Albert|||0000-0002-4820-0736
  • López Ayerbe, Jorge|||0009-0008-8495-0877
  • Juncà Puig, Gladys|||0000-0002-4421-5658
  • Gual-Capllonch, Francisco
  • Ferrer Sistach, Elena
  • Vivero, Ainhoa
  • Reynaga, Esteban|||0000-0002-4069-6087
  • Hernández-Pérez, María|||0000-0001-8279-7954
  • Muñoz-Guijosa, Christian|||0000-0002-0272-1704
  • Pedro Botet, Maria Luisa|||0000-0001-7252-3191
  • Bayés-Genís, Antoni|||0000-0002-3044-197X
Background: To date, there is little information regarding management of patients with infective endocarditis (IE) that did not undergo an indicated surgery. Therefore, we aimed to evaluate prognosis of these patients treated with a long-term antibiotic treatment strategy, including oral long term suppressive antibiotic treatment in five referral centres with a multidisciplinary endocarditis team. Methods: This retrospective, multicenter study retrieved individual patient-level data from five referral centres in Spain. Among a total of 1797, 32 consecutive patients with IE were examined (median age 72 years; 78% males) who had not undergone an indicated surgery, but received long-term antibiotic treatment (LTAT) and were followed by a multidisciplinary endocarditis team, between 2011 and 2019. Primary outcomes were infection relapse and mortality during follow-up. Results: Among 32 patients, 21 had IE associated with prostheses. Of the latter, 8 had an ascending aorta prosthetic graft. In 24 patients, a switch to long-term oral suppressive antibiotic treatment (LOSAT) was considered. The median duration of LOSAT was 277 days. Four patients experienced a relapse during follow-up. One patient died within 60 days, and 12 patients died between 60 days and 3 years. However, only 4 deaths were related to IE. Conclusions: The present study results suggest that a LTAT strategy, including LOSAT, might be considered for patients with IE that cannot undergo an indicated surgery. After hospitalization, they should be followed by a multidisciplinary endocarditis team.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Virgin Olive Oil Phenolic Compounds Modulate the HDL Lipidome in Hypercholesterolaemic Subjects, A Lipidomic Analysis of the VOHF Study

  • Fernández-Castillejo, Sara|||0000-0002-8109-9713
  • Pedret, Anna
  • Catalán, Úrsula
  • Valls, Rosa Maria|||0000-0002-3351-0942
  • Farràs Mañé, Marta|||0000-0001-9776-3773
  • Rubió, Laura
  • Castañer, Olga|||0000-0003-3169-997X
  • Macià, Alba
  • Fitó, Montserrat|||0000-0002-1817-483X
  • Motilva, Maria José
  • Covas Planells, Maria Isabel
  • Giera, Martin
  • Remaley, Alan T.
  • Solà, Rosa|||0000-0002-8359-235X
Scope: The lipidomic analysis of high-density lipoprotein (HDL) could be useful to identify new biomarkers of HDL function. Methods and results: A randomized, controlled, double-blind, crossover trial (33 hypercholesterolaemic subjects) is performed with a control virgin olive oil (VOO), VOO enriched with its own phenolic compounds (FVOO), or VOO enriched with additional phenolic compounds from thyme (FVOOT) for 3 weeks. HDL lipidomic analyses are performed using the Lipidyzer platform. VOO and FVOO intake increase monounsaturated-fatty acids (FAs) and decrease saturated and polyunsaturated FAs in triacylglyceride (TAG) species, among others species. In contrast, FVOOT intake does not induce these FAs changes. The decrease in TAG52:3(FA16:0) after VOO intake and the decrease in TAG52:5(FA18:2) after FVOO intake are inversely associated with changes in HDL resistance to oxidation. After FVOO intake, the decrease in TAG54:6(FA18:2) in HDL is inversely associated with changes in HDL cholesterol efflux capacity. Conclusion: VOO and FVOO consumption has an impact on the HDL lipidome, in particular TAG species. Although TAGs are minor components of HDL mass, the observed changes in TAG modulated HDL functionality towards a cardioprotective mode. The assessment of the HDL lipidome is a valuable approach to identify and characterize new biomarkers of HDL function.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

A functional virgin olive oil enriched with olive oil and thyme phenolic compounds improves the expression of cholesterol efflux-related genes, A randomized, crossover, controlled trial

  • Farràs Mañé, Marta|||0000-0001-9776-3773
  • Arranz, Sara|||0000-0003-2397-5145
  • Carrión, Silvia|||0000-0002-1354-2488
  • Subirana, Isaac|||0000-0003-1676-0197
  • Muñoz Aguayo, Daniel|||0000-0001-8173-0168
  • Blanchart, Gemma|||0000-0003-1965-8235
  • Kool, Marjon
  • Solà, Rosa|||0000-0002-8359-235X
  • Motilva, María José
  • Escolà-Gil, Joan Carles|||0000-0001-9021-2485
  • Rubió, Laura
  • Fernández-Castillejo, Sara|||0000-0002-8109-9713
  • Pedret, Anna
  • Estruch, Ramón|||0000-0003-1260-4445
  • Covas Planells, Maria Isabel
  • Fitó, Montserrat|||0000-0002-1817-483X
  • Hernáez, Álvaro|||0000-0001-8593-1477
  • Castañer, Olga|||0000-0003-3169-997X
The consumption of antioxidant-rich foods such as virgin olive oil (VOO) promotes high-density lipoprotein (HDL) anti-atherogenic capacities. Intake of functional VOOs (enriched with olive/thyme phenolic compounds (PCs)) also improves HDL functions, but the gene expression changes behind these benefits are not fully understood. Our aim was to determine whether these functional VOOs could enhance the expression of cholesterol efflux-related genes. In a randomized, double-blind, crossover, controlled trial, 22 hypercholesterolemic subjects ingested for three weeks 25 mL/day of: (1) a functional VOO enriched with olive oil PCs (500 mg/kg); (2) a functional VOO enriched with olive oil (250 mg/kg) and thyme PCs (250 mg/kg; FVOOT), and; (3) a natural VOO (olive oil PCs: 80 mg/kg, control intervention). We assessed whether these interventions improved the expression of cholesterol efflux-related genes in peripheral blood mononuclear cells by quantitative reverse-transcription polymerase chain reactions. The FVOOT intervention upregulated the expression of CYP27A1 (P = 0.041 and P = 0.053, versus baseline and the control intervention, respectively), CAV1 (P = 0.070, versus the control intervention), and LXRβ, RXRα, and PPARβ/δ (P = 0.005, P = 0.005, and P = 0.038, respectively, relative to the baseline). The consumption of a functional VOO enriched with olive oil and thyme PCs enhanced the expression of key cholesterol efflux regulators, such as CYP27A1 and nuclear receptor-related genes.
Scientia. Dipòsit d'Informació Digital del Departament de Salut
Publication Artículo científico (JournalArticle)

Spontaneous portosystemic shunt embolization in liver transplant recipients with recurrent hepatic encephalopathy

  • Álvarez López, Patricia
  • Quiroga Gómez, Sergi
  • Díez Miranda, Iratxe
  • Charco Torra, Ramon
  • Simon-Talero Horga, Macarena
  • Castells Fusté, Lluis
  • Campos Varela, Isabel
Angiogenesis; Portal hypertension; Collateral vessels, Angiogénesis; Hipertensión portal; Vasos colaterales, Angiogènesi; Hipertensió portal; Vasos col·laterals, Introduction and objectives Spontaneous portosystemic shunts (SPSS) are a common cause of recurrent hepatic encephalopathy (HE). Shunt occlusion is an effective and safe procedure when performed in patients with cirrhosis and preserved liver function. We aimed to describe our experience with SPSS embolization after liver transplantation (LT). Patients We identified five patients who underwent SPSS embolization after LT. Clinical, biochemical and technical procedure data were collected. Results At presentation, all patients had developed graft cirrhosis and HE after LT. Median Model for End-stage Liver Disease (MELD) at embolization was 9 (range 7-12), median Child-Pugh was 8 (range 7-9). Splenorenal and mesocaval shunt were the most frequent types of SPSS found. Three patients have been completely free of HE. Of the two patients who had HE recurrence after embolization, one patient had two episodes of HE which was controlled well with medications. The other patient required three embolizations because of recurrent HE. Median follow-up was 4.4 years (range 1.0-5.0) and MELD score at last follow up was 13 (range 10-18) and median Child-Pugh score B, 7 points (range 5-12). Conclusions SPSS can be considered as a cause of HE after LT. SPSS embolization is feasible and safe in LT recipients., Isabel Campos-Varela's research activity is funded by grant PI19/00330, funded by Instituto de Salud Carlos III and co-funded by European Union (ERDF/ESF) - A way to build Europe. Macarena Simón-Talero is a recipient of the Juan Rodés grant JR17/00029 from Instituto de Salud Carlos III, Spain. CIBERehd is supported by Instituto de Salud Carlos III. The work was independent of all funding.